Search results
Marc Trevor Tessier-Lavigne OC FRS FRSC FMedSci (born December 18, 1959) is a Canadian-American neuroscientist who was the eleventh president of Stanford University. Previously, he was a professor at the University of California, San Francisco and then president of Rockefeller University in New York City.
- 3
- Richard Saller (acting)
Biography. Pioneering neuroscientist, biotechnology executive and academic leader Marc Tessier-Lavigne served as Stanford University’s eleventh president from September 2016 through August 2023. Marc Tessier-Lavigne. Dr. Tessier-Lavigne was born in Trenton, Ontario, Canada. He received undergraduate degrees in physics from McGill University ...
Marc Tessier-Lavigne is a pioneering neuroscientist, biotechnology executive, and academic leader. He served as Stanford University’s eleventh president from September 2016 through August 2023.
Marc Tessier-Lavigne, Curriculum Vitae. Address: Born: Nationality: Office of the President, Stanford University, 450 Jane Stanford Way, Building 10, Stanford, CA 94305. December 18, 1959; Trenton, Ontario, Canada. Canada and USA. Education: 1977-1980 1980-1982 1983-1987. B.Sc., First Class Honors, Physics, McGill University, Montreal. B.A.,
- 231KB
- 26
People. Marc Tessier-Lavigne. Bing Presidential Professor. Head of Laboratory. Marc received undergraduate degrees from McGill University and from Oxford University, where he was a Rhodes Scholar, and a Ph.D. from University College London (UCL).
People also ask
Who is Marc Tessier-Lavigne?
When did John Tessier-Lavigne resign?
Did Jacques Tessier-Lavigne fabricate research results?
Feb 4, 2016 · Pioneering neuroscientist, biotechnology executive and academic leader, Marc Tessier-Lavigne is President of The Rockefeller University, a leading biomedical research university in New York City. Marc Tessier-Lavigne. Dr. Tessier-Lavigne was born in Trenton, Ontario, Canada.
He was formerly executive vice president for research and chief scientific officer at Genentech. As of 2021, he is on the boards of directors of Denali Therapeutics and Regeneron Pharmaceuticals, as well as the scientific advisory boards of Denali Therapeutics and Agios Pharmaceuticals.
